期刊
TRENDS IN BIOTECHNOLOGY
卷 38, 期 4, 页码 360-367出版社
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tibtech.2019.09.009
关键词
-
资金
- Be READY project - Sciensano
Next-generation sequencing (NGS) can enable a more effective response to a wide range of communicable disease threats, such as influenza, which is one of the leading causes of human morbidity and mortality worldwide. After vaccination, antivirals are the second line of defense against influenza. The use of currently available antivirals can lead to antiviral resistance mutations in the entire influenza genome. Therefore, the methods to detect these mutations should be developed and implemented. In this Opinion, we assess how NGS could be implemented to detect drug resistance mutations in clinical influenza virus isolates.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据